Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SINTthis companySintx Technologies, Inc.	$1.61	-0.63×	3.66×	10.52×	-1.02×	-554.2%	-19.7%	-1053.1%	-1678.1%	-583.2%	-173.5%	-81.8%	1.11×	0.09×	-206.17×	1.51×	0.0%	3	-41.74	1	C-
HSCSHeartSciences Inc.	$2.91	-0.56×	0.02×	1,185.36×	-275.91×	-25040.1%	-2982.1%	-194787.4%	-211666.5%	-4.1%	-0.2%	-145.9%	17.46×	-275.29×	-11.17×	0.53×	0.0%	1	-41.58	2	C
PFSAProfusa, Inc. Common Stock	$0.55	-7.35×	-9.87×	0×	-8.99×	-8597.3%	0.0%	0.0%	0.0%	134.4%	114.5%	-6.2%	-0.56×	-0.42×	-2.6×	0.17×	0.0%	2	-374.82	2	C
RNAZTransCode Therapeutics, Inc.	$1.59	-0.13×	0.46×	0×	0.38×	1495.1%	0.0%	0.0%	0.0%	-335.4%	-17.6%	-414.4%	0×	0.52×	-4,229.15×	6.29×	0.0%	0	-1.94	3	B
TNONTenon Medical, Inc.	$1.73	-0.56×	1.39×	1.78×	-0.28×	-116666.0%	59.8%	-324.3%	-318.4%	-249.1%	-166.4%	-156.8%	0.03×	0.3×	0×	2.11×	0.0%	3	-16.68	2	C
XAIRBeyond Air, Inc.	$2.26	-3.44×	18.7×	14.92×	-4.28×	513.4%	3.3%	-378.2%	-433.0%	-542.8%	-98.1%	-16.7%	3.82×	-0.54×	0×	3.8×	0.0%	3	-16.43	1	D+
Peer median	—	-0.56×	0.46×	1.78×	-4.28×	-8597.3%	0.0%	-324.3%	-318.4%	-249.1%	-17.6%	-145.9%	0.03×	-0.42×	-2.6×	2.11×	0.0%	2	-16.68	2	—